Di
Non vérifié

Diamyd Medical AB

Ce que nous écrivons

ÉconomieFinanceIndustrie pharmaceutiqueSanté PubliqueStart-up
23/03/2026
Santé
Fitness/Bien-être
Finance
Épargne/Affaires personnelles
Fonds d'investissement
Médecine - Divers
Écologie/Santé environnementale
Agriculture
Diamyd Medical enters into equity financing agreements with new U.S. sector specialist investors for up to USD 125 million and announces full enrollment in Phase 3 trial
1.00
21/04/2025
Industrie pharmaceutique
Santé Publique
Média
Communication
Économie
Start-up
Diamyd Medical highlights opportunity in Type 1 Diabetes prevention, adult-onset market, and upcoming Phase 3 readout
1.00
12/02/2025
Industrie pharmaceutique
Santé Publique
Banque
Finance
Hypothèques
Épargne/Affaires personnelles
Leasing
Gestion des obligations
Fonds d'investissement
Euro-obligations
Diamyd Medical announces expanded financial support from Breakthrough T1D
1.00
13/01/2025
Industrie pharmaceutique
Santé Publique
Économie
Start-up
Biologie
Diamyd Medical updates U.S. market potential for Diamyd®
1.00
10/01/2025
Industrie pharmaceutique
Santé Publique
Économie
Start-up
Finance
Biologie
Diamyd Medical confirms key advances toward Accelerated Approval for Diamyd® following FDA Type C Meeting
1.00
13/12/2024
Industrie pharmaceutique
Santé Publique
Diamyd Medical Aligns with FDA on Key Elements for an Accelerated Approval Process
1.00
21/11/2024
Industrie pharmaceutique
Santé Publique
Économie
Start-up
Diamyd Medical hits a recruitment milestone in DIAGNODE-3 Phase 3 trial
1.00
09/09/2024
Industrie pharmaceutique
Santé Publique
Économie
Start-up
Diamyd Medical to pursue accelerated approval pathway for Type 1 Diabetes precision medicine
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0